Decreased Growth with Serotonin Reuptake Inhibitors

Growth and growth hormone secretion were evaluated in 4 children (3 boys), aged 11.6 to 13.7 years, treated with selective serotonin reuptake inhibitors (SSRIs) for obsessive compulsive disorder or Tourette syndrome, at Schneider Children’s Medical Center of Israel, Petah Tikva, and Sackler School o...

Description complète

Détails bibliographiques
Auteur principal: J Gordon Millichap
Format: Article
Langue:English
Publié: Pediatric Neurology Briefs Publishers 2002-08-01
Collection:Pediatric Neurology Briefs
Sujets:
Accès en ligne:https://www.pediatricneurologybriefs.com/articles/1603